Citi cuts ArriVent BioPharma price target to $40 Aug 13, 2026 06:12AM
ArriVent BioPharma (AVBP) PT Lowered to $43 at Citi May 12, 2026 09:59AM
Citi Opens 90-Day Upside Catalyst Watch on ArriVent BioPharma (AVBP) Apr 24, 2026 05:06AM
ArriVent Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants Jul 1, 2025 11:15PM
ArriVent BioPharma (AVBP) Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants Jul 1, 2025 04:05PM


Jul 1, 2025 04:05PM ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants
Jun 23, 2025 12:47PM ArriVent BioPharma (AVBP) PT Raised to $40 at Citi, Adding 90d Upside Catalyst Watch
Sep 10, 2024 11:49AM ArriVent BioPharma (AVBP) PT Raised to $36 at Citi
Feb 20, 2024 03:54AM Citi Starts ArriVent BioPharma (AVBP) at Buy, 'Leader of the PACC in the EGFR Exon 20 TKI Race'
Jan 5, 2024 04:20PM ArriVent BioPharma (AVBP) Announces Proposed IPO